Zoekresultaten - Gro Kvelprud Moen

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stoppi... door Richard Haynes, Lixin Jiang, Jemma C. Hopewell, Jing Li, F Chen, Sarah Parish, Martin Landray, Robert G. Collins, W. John Armitage, Robert G. Collins, W. John Armitage, C. Baigent, Z. Chen, Martin Landray, Yang Chen, Lixin Jiang, Terje Pedersen, Martin Landray, Louise Bowman, F Chen, Michael Hill, Richard Haynes, Carol Knott, Kazem Rahimi, Jonathan A. Tobert, Peter Sleight, David Simpson, Sarah Parish, Alex Baxter, M. Lay, Christopher Bray, E. Wincott, G. van Leijenhorst, A. Skattebøl, Gro Kvelprud Moen, Yale Mitchel, O. Kuznetsova, Stephen MacMahon, John Kjekshus, Catherine J. Hill, TH Lam, Peter Sandercock, Richard Peto, Jemma C. Hopewell

Volledige tekst Volledige tekst